Gapping up
In reaction to strong earnings/guidance/SSS: WGBS +17.8%, MG +16%, EDUC +9.2%, RELL +5.2%, ZUMZ +3.8%, NXTD +2.9%, RECN +1.9%, DB +0.6%, (announces anticipated Q3 charges - rebounding from yday's sell-off), CONN +0.4%
M&A news: JMG +42.2% (to be acquired by Gannett (GCI) for $12 per share), BMR +8.2% (to be acquired by Blackstone (BX) for $23.75/share in an $8 bln deal), EMC +4.2% (in talks to merge with Dell, according to the WSJ), CC +3.6% (pollo Global Management (APO) may consider an offer to acquire CC, according to Bloomberg), ECA +2.7% (to sell its Denver Julesburg Basin assets in Colorado for ~$900 mln), TLN +2.1% (agrees to sell three Pennsylvania power plants, with 996 MW of capacity, for $1.51 bln in cash)
Select metals/mining stocks trading higher: AU +3.8%, BHP +2.5%, MT +1.9%, BBL +1.6%, FCX +1.5%, CLF +1.4%, VALE +0.8%
Other news: GBSN +40.9% (submits its Shiga Toxin Direct Test to the FDA for 510(k) clearance following the successful completion of a clinical trial that met all of Great Basin's clinical objectives), SD +16% (announces it will repurchase $100 mln of its senior unsecured notes for $30 mln in cash, and exchange $300 mln of senior unsecured notes for convertible notes ), NBIX +15.6% (announces that NBI-98854 showed a statistically significant reduction in tardive dyskinesi, during a Kinect 3 clinical trial), CDTI +14.6% (Clean Diesel Technologies and PACCAR (PACR) sign multi-year Distribution Agreement for DuraFit), NVLS +11.8% (announced positive Phase 1b results for N91115 in patients with Cystic Fibrosis), OGXI+11.1% (announces the EMA supports plans for prospectively defining poor prognostic subpopulation in Ph 3 AFFINITY trial), LL +8% ( reaches a settlement with the DOJ related to compliance with the Lacey Act, regarding the protection of plants, fish and wildlife ), BTX +6.3% (OncoCyte subsidiary filed Registration Statement with the SEC in connection with co's planned distribution OncoCyte common stock to holders of BioTime), MBLX +4% (announces $20 million common stock purchase agreement with Aspire Capital Fund), INTL +3.1% (to replace AMSG in the S&P SmallCap 600), RAX +2.1% (cont strength), SNDK +2.1% (cont strength, rumored to be takeover target earlier this week), SLRC +1.7% (announces a $30 million repurchase program), ASML +1.7% (still checking), ALKS +1.7% (favorable commentary on Wednesday's Mad Money), FCAU +1.3% (confirms new tentative agreement with the UAW ), AMSG +1.2% (to replace CNW in the S&P MidCap 400), RBA +1% (reported September gross auction proceeds)
Analyst comments: QLYS +6.2% (upgraded to Outperform from Neutral at Credit Suisse), TLYS +4.6% (upgraded to Buy from Neutral at B. Riley & Co), LOCO +3.4% (initiated with a Buy at Sun Trust Rbsn Humphrey), NAVI +3.1% (upgraded to Buy from Neutral at Goldman), PAY +2.4% (upgraded to Strong Buy from Outperform at Raymond James), NKE +0.6% (upgraded to Buy at DA Davidson)
In reaction to strong earnings/guidance/SSS: WGBS +17.8%, MG +16%, EDUC +9.2%, RELL +5.2%, ZUMZ +3.8%, NXTD +2.9%, RECN +1.9%, DB +0.6%, (announces anticipated Q3 charges - rebounding from yday's sell-off), CONN +0.4%
M&A news: JMG +42.2% (to be acquired by Gannett (GCI) for $12 per share), BMR +8.2% (to be acquired by Blackstone (BX) for $23.75/share in an $8 bln deal), EMC +4.2% (in talks to merge with Dell, according to the WSJ), CC +3.6% (pollo Global Management (APO) may consider an offer to acquire CC, according to Bloomberg), ECA +2.7% (to sell its Denver Julesburg Basin assets in Colorado for ~$900 mln), TLN +2.1% (agrees to sell three Pennsylvania power plants, with 996 MW of capacity, for $1.51 bln in cash)
Select metals/mining stocks trading higher: AU +3.8%, BHP +2.5%, MT +1.9%, BBL +1.6%, FCX +1.5%, CLF +1.4%, VALE +0.8%
Other news: GBSN +40.9% (submits its Shiga Toxin Direct Test to the FDA for 510(k) clearance following the successful completion of a clinical trial that met all of Great Basin's clinical objectives), SD +16% (announces it will repurchase $100 mln of its senior unsecured notes for $30 mln in cash, and exchange $300 mln of senior unsecured notes for convertible notes ), NBIX +15.6% (announces that NBI-98854 showed a statistically significant reduction in tardive dyskinesi, during a Kinect 3 clinical trial), CDTI +14.6% (Clean Diesel Technologies and PACCAR (PACR) sign multi-year Distribution Agreement for DuraFit), NVLS +11.8% (announced positive Phase 1b results for N91115 in patients with Cystic Fibrosis), OGXI+11.1% (announces the EMA supports plans for prospectively defining poor prognostic subpopulation in Ph 3 AFFINITY trial), LL +8% ( reaches a settlement with the DOJ related to compliance with the Lacey Act, regarding the protection of plants, fish and wildlife ), BTX +6.3% (OncoCyte subsidiary filed Registration Statement with the SEC in connection with co's planned distribution OncoCyte common stock to holders of BioTime), MBLX +4% (announces $20 million common stock purchase agreement with Aspire Capital Fund), INTL +3.1% (to replace AMSG in the S&P SmallCap 600), RAX +2.1% (cont strength), SNDK +2.1% (cont strength, rumored to be takeover target earlier this week), SLRC +1.7% (announces a $30 million repurchase program), ASML +1.7% (still checking), ALKS +1.7% (favorable commentary on Wednesday's Mad Money), FCAU +1.3% (confirms new tentative agreement with the UAW ), AMSG +1.2% (to replace CNW in the S&P MidCap 400), RBA +1% (reported September gross auction proceeds)
Analyst comments: QLYS +6.2% (upgraded to Outperform from Neutral at Credit Suisse), TLYS +4.6% (upgraded to Buy from Neutral at B. Riley & Co), LOCO +3.4% (initiated with a Buy at Sun Trust Rbsn Humphrey), NAVI +3.1% (upgraded to Buy from Neutral at Goldman), PAY +2.4% (upgraded to Strong Buy from Outperform at Raymond James), NKE +0.6% (upgraded to Buy at DA Davidson)